Pharmacodynamic variability beyond that explained by MICs.

Item

http://www.wikidata.org/entity/Q36757639

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Pharmacodynamic variability beyond that explained by MICs.

@ast

Pharmacodynamic variability beyond that explained by MICs.

@en

type

Item

label

Pharmacodynamic variability beyond that explained by MICs.

@ast

Pharmacodynamic variability beyond that explained by MICs.

@en

prefLabel

Pharmacodynamic variability beyond that explained by MICs.

@ast

Pharmacodynamic variability beyond that explained by MICs.

@en

P1476

Pharmacodynamic variability beyond that explained by MICs.

@en

P2093

Alan Forrest

http://www.w3.org/2001/XMLSchema#string

Brian Tsuji

http://www.w3.org/2001/XMLSchema#string

Gauri Rao

http://www.w3.org/2001/XMLSchema#string

Kuo Yang

http://www.w3.org/2001/XMLSchema#string

Lance Wollenberg

http://www.w3.org/2001/XMLSchema#string

Neang S Ly

http://www.w3.org/2001/XMLSchema#string

Rachel L Soon

http://www.w3.org/2001/XMLSchema#string

P2860

Overview of seizure-inducing potential of doripenem

Population pharmacokinetics of doripenem based on data from phase 1 studies with healthy volunteers and phase 2 and 3 studies with critically ill patients.

Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenem

Comparative pharmacokinetics of the carbapenems: clinical implications.

In vivo efficacy of simulated human dosing regimens of prolonged-infusion doripenem against carbapenemase- producing Klebsiella pneumoniae.

Role of pharmacodynamics in designing dosage regimens for beta-lactams.

Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid.

Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.

Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists.

In vivo pharmacodynamic profiling of doripenem against Pseudomonas aeruginosa by simulating human exposures.

P304

1730-1735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01224-12

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235379265

http://www.w3.org/2001/XMLSchema#string

P698

23357773

http://www.w3.org/2001/XMLSchema#string

P932

3623339

http://www.w3.org/2001/XMLSchema#string